Sialic acid biophore directed design of enhanced affinity HN protein from Newcastle disease virus
The FEBS Journal · 2026-08 · 293 (16) · 4943-4967
DOI: 10.1111/febs.70493 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 03.04.2026. Verfasst von Siddharth Neog und 3 weiteren Autor:innen. Beteiligte Einrichtung: Malaria Research Group, Department of Biosciences and Bioengineering, Indian Institute of Technology-Guwahati, Assam, India. Hauptthemen laut MEDLINE: Newcastle disease virus, HN Protein, N-Acetylneuraminic Acid. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The hemagglutinin‐neuraminidase (HN) of Newcastle disease virus (NDV) is a multifunctional protein that mediates virus attachment to host sialic acid‐containing receptors, exhibits neuraminidase activity, and promotes membrane fusion. Notably, purified HN protein also targets sialic acids on malaria‐parasitised red blood cells (PRBCs), thereby reducing parasite viability, and is thus a potential therapeutic molecule against the malaria parasite. To gain further insights into the structural and functional basis of its sialic acid recognition, we performed comparative analyses of the sialic acid‐binding pocket across different viral lectins. It revealed a Type‐VI sialic acid‐binding module in HN, characterised by fewer interactions with the functional groups of sialic acid compared to Type‐I influenza neuraminidases (NA). Introduction of a rationale‐based specific mutation (I175Y) in the central binding pocket of HN transformed its sialic acid‐binding module from Type‐VI to Type‐I. It resulted in significantly higher affinity for sialic acid, accompanied by a substantial loss in its neuraminidase activity. This disruption in the delicate functional balance between receptor‐binding and enzymatic cleavage highlights a trade‐off between optimising one activity at the cost of another. Biologically, the mutant HN exhibited enhanced hemadsorption, or cell‐binding activity, and thus showed greater ability to block NDV replication in both cell monolayers and in‐ovo systems. The mutant protein also demonstrated an increased capacity to target PRBCs and showed potent anti‐plasmodial activity, compared to the wild‐type. This enhanced targeting capability highlights the mutant as a promising candidate for developing precision drug delivery systems for malaria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Malaria Research Group, Department of Biosciences and Bioengineering, Indian Institute of Technology-Guwahati, Assam, India.
- Viral Immunology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology-Guwahati, Assam, India.
ORCID-Profile: Siddharth Neog, Vishal Trivedi
Zitieren
APA
Neog, S., Kumar, S., Nandy, S., & Trivedi, V. (2026). Sialic acid biophore directed design of enhanced affinity HN protein from Newcastle disease virus. The FEBS Journal, 293(16), 4943-4967. https://doi.org/10.1111/febs.70493
Vancouver
Neog S, Kumar S, Nandy S, Trivedi V. Sialic acid biophore directed design of enhanced affinity HN protein from Newcastle disease virus. The FEBS Journal. 2026;293(16):4943-4967. doi:10.1111/febs.70493
BibTeX
@article{Neog2026,
author = {Neog, Siddharth and Kumar, Sachin and Nandy, Satyendu and Trivedi, Vishal},
title = {Sialic acid biophore directed design of enhanced affinity HN protein from Newcastle disease virus},
journal = {The FEBS Journal},
year = {2026},
volume = {293},
number = {16},
pages = {4943--4967},
doi = {10.1111/febs.70493}
}
EUVIMED